![Peter Meier-Abt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter Meier-Abt
Corporate Officer/Principal presso University of Basel
Profilo
Dr. Peter Meier-Abt is a Principal at University of Basel.
He is on the Board of Directors at ErfindungsVerwertung AG.
Posizioni attive di Peter Meier-Abt
Società | Posizione | Inizio |
---|---|---|
University of Basel | Corporate Officer/Principal | 23/06/2011 |
Precedenti posizioni note di Peter Meier-Abt
Società | Posizione | Fine |
---|---|---|
ErfindungsVerwertung AG
![]() ErfindungsVerwertung AG Miscellaneous Commercial ServicesCommercial Services ErfindungsVerwertung AG engages in the provision of seed capital as well as consulting and market research services to startup companies in the field of life sciences. It offers project and business plan reviews, financial planning, business set-up, coaching, and assistance to find venture capital. The firm supports life sciences researchers, initiators of university projects, developers, and inventors in the field of drug development, medical technology, diagnostics, biomedicine, and nanotechnology. The company was founded in 1996 and is headquartered in Basel, Switzerland. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
ErfindungsVerwertung AG
![]() ErfindungsVerwertung AG Miscellaneous Commercial ServicesCommercial Services ErfindungsVerwertung AG engages in the provision of seed capital as well as consulting and market research services to startup companies in the field of life sciences. It offers project and business plan reviews, financial planning, business set-up, coaching, and assistance to find venture capital. The firm supports life sciences researchers, initiators of university projects, developers, and inventors in the field of drug development, medical technology, diagnostics, biomedicine, and nanotechnology. The company was founded in 1996 and is headquartered in Basel, Switzerland. | Commercial Services |
- Borsa valori
- Insiders
- Peter Meier-Abt